CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Influx Healthtech Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Influx Healthtech Ltd
109
Ghanshyam Enclave Premises Co-op Soc
Phone: +91 8080333319p:+91 8080333319 MUMBAI, 400067  India Ticker: INFLUXINFLUX
Business Summary
Influx Healthtech Limited is an India-based healthcare product-focused company. The Company operates as a contract development and manufacturing organization. It specializes in a diverse range of products across several segments, including dietary/nutritional supplements, cosmetics, ayurvedic/herbal, veterinary feed supplements and homecare segments. This includes the production of active pharmaceutical ingredients and the manufacturing of finished dosage forms such as tablets, capsules, and injectables. It manufactures dietary and nutritional supplements in the form of tablets, capsules, powders, liquid orals, soft gels, lozenges, jellies, oral dispersible films, candies, gummies and effervescent tablets, and others. It manufactures cosmetics products for men and women, which include skincare and body care products, hair care and beard care solutions, and face masks and soaps. It manufactures ayurvedic formulations in the form of tablets, capsules, powder, liquid orals and others.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20243/31/2024-----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2844 Perfumes, cosmetics, and other toilet preparations
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Managing Director Munir AbdulGanee Chandniwala 44 7/26/2024 9/28/2020
Chief Financial Officer Ashish G.Shah 45 5/2/2024 5/2/2024
Compliance Officer, Company Secretary Atul Kumar A.Shukla 35 5/2/2024 5/2/2024
4 additional Officers and Directors records available in full report.

General Information
Stock Exchange: NSE


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, June 27, 2025